Company News

Share this article:

GlaxoSmithKline announced that it will form a joint venture with China-based Jiangsu Walvax Biotech Company to develop pediatric vaccines for measles, mumps and rubella in China. GSK is investing $29.7 million in the deal initially, and will invest an additional $10.7 million in 2015, according to a company statement.

EMD Serono Canada tapped Ariad Healthcare to market its probiotic multivitamin Multibionta – the number one selling multivitamin in France and the UK – in Canada. Other partners on the assignment include Rao Barrett & Welsh, Environics and M2 Universal.


Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.